Recombinant Human DZIP1 Protein, N-His-SUMO from ProteoGenix; catalogue ARO-P11397; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human DZIP1 Protein, also known as DAZ-interacting protein 1, is a protein that is encoded by the DZIP1 gene in humans. It is a member of the DAZ family of proteins, which are involved in the regulation of germ cell development and male fertility. Recombinant Human DZIP1 Protein is produced through genetic engineering techniques, making it a highly purified and biologically active protein.
Recombinant Human DZIP1 Protein is a 70 kDa protein consisting of 626 amino acids. It contains a DAZ-like domain, a conserved zinc finger domain, and a proline-rich region. The DAZ-like domain is responsible for the interaction with DAZ proteins, while the zinc finger domain is involved in RNA binding. The proline-rich region is thought to play a role in protein-protein interactions.
Recombinant Human DZIP1 Protein is a key regulator of germ cell development and male fertility. It has been shown to interact with DAZ proteins, which are essential for spermatogenesis. DAZ proteins are RNA-binding proteins that are involved in the translation and stabilization of mRNAs that are critical for germ cell development. Recombinant Human DZIP1 Protein enhances the RNA-binding activity of DAZ proteins, thereby promoting the translation of specific mRNAs and ultimately leading to the development and maturation of sperm cells.
In addition to its role in germ cell development, Recombinant Human DZIP1 Protein has also been found to be involved in the regulation of the Wnt signaling pathway. This pathway plays a crucial role in various cellular processes, including cell proliferation, differentiation, and apoptosis. Recombinant Human DZIP1 Protein has been shown to interact with key components of the Wnt signaling pathway, such as β-catenin and GSK-3β, and modulate their activity. This suggests that Recombinant Human DZIP1 Protein may have a broader role in cellular signaling and development beyond its involvement in germ cell development.
Recombinant Human DZIP1 Protein has a wide range of potential applications in both research and therapeutic settings. Its role in germ cell development and male fertility makes it a valuable tool for studying the mechanisms of spermatogenesis and identifying potential targets for male infertility treatments.
Moreover, the interaction of Recombinant Human DZIP1 Protein with key components of the Wnt signaling pathway makes it a potential target for the development of novel therapies for diseases such as cancer. Dysregulation of the Wnt signaling pathway has been implicated in various types of cancer, and targeting Recombinant Human DZIP1 Protein could potentially lead to the development of more effective treatments.
In addition, Recombinant Human DZIP1 Protein has been used in in vitro studies to investigate its role in RNA binding and translation. Its ability to enhance the RNA-binding activity of DAZ proteins makes it a valuable tool for studying the regulation of gene expression and identifying potential therapeutic targets for diseases related to RNA dysregulation.
In summary, Recombinant Human DZIP1 Protein is a 70 kDa protein that plays a crucial role in germ cell development and male fertility. Its interaction with DAZ proteins and modulation of the Wnt signaling pathway make it a promising target for research and therapeutic applications. Its production through genetic engineering techniques ensures a highly pure and biologically active protein, making it a valuable tool for scientific studies. Further research on Recombinant Human DZIP1 Protein may lead to a better understanding of its role in cellular signaling and the development of new treatments for diseases related to germ cell development and RNA dysregulation.
ProteoGenix catalogue number ARO-P11397. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 17.80 kDa; Fragment: Ser66-Asp114; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
